You are here: All Products  > Innovent Will Trial its PD-1 With Xuanzhu’s HER-2 ADC for Solid Tumor Cancers

Innovent Will Trial its PD-1 With Xuanzhu’s HER-2 ADC for Solid Tumor Cancers

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products